{"id":"W2588974371","doi":"10.1111/dom.12909","title":"Lipid‐lowering efficacy and safety of alirocumab in patients with or without diabetes: <scp>A</scp> sub‐analysis of <scp>ODYSSEY COMBO II</scp>","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Ezetimibe; PCSK9; Medicine; Statin; Internal medicine; Adverse effect; Diabetes mellitus; Gastroenterology; Urology; Pharmacology; Endocrinology; Cholesterol; Lipoprotein; LDL receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00110876,0.0003787147,0.002282355,0.0004620529,0.0003497202,0.00005193205,0.0002417197,0.0002164236,0.000003634167],"category_scores_gemma":[0.001084479,0.0002792809,0.000286526,0.0004972453,0.0003641363,0.0002847935,0.0002768773,0.0003096563,9.023591e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002816919,"about_ca_system_score_gemma":0.0001001742,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003047846,"about_ca_topic_score_gemma":0.0001482389,"domain_scores_codex":[0.9973519,0.0001309949,0.0006396552,0.0005747459,0.0006837429,0.000618946],"domain_scores_gemma":[0.9974131,0.0002832815,0.000538388,0.001139887,0.0002754202,0.0003499445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00005296304,0.0006236415,0.9880922,0.0006943669,0.002622033,0.000002548141,0.00110638,0.00001199096,0.0006536381,0.00005032474,0.00001702814,0.006072827],"study_design_scores_gemma":[0.008122731,0.0003898134,0.9732131,0.0004374701,0.004194916,4.32139e-7,0.0001317101,0.0001538301,0.01151057,0.00001386409,0.001743649,0.00008789388],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956185,0.002889939,0.00002222029,0.00002314222,0.0001171298,0.0009496096,0.00009155938,0.00002798667,0.000259896],"genre_scores_gemma":[0.9982558,0.001026923,0.0002713797,0.0001095423,0.000105909,0.00002789819,0.00006235347,0.00003970776,0.0001004754],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01487914,"threshold_uncertainty_score":0.999966,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008596369459351293,"score_gpt":0.2316953941564273,"score_spread":0.223099024697076,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}